Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma
- PMID: 30404735
- DOI: 10.1016/j.bbrc.2018.10.186
Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma
Abstract
Background: Long non-coding RNAs (lncRNAs) can interact with microRNAs (miRNAs) as a competing endogenous RNA (ceRNA) to regulate the expression of target genes, which can largely influence on tumorigenesis and tumor progression. However, the role of lncRNA-mediated ceRNAs in cholangiocarcinoma (CCA) remains unknown. This study aimed to develop novel lncRNAs as well as their action mechanisms in CCA.
Methods: The expression profiles of lncRNAs, miRNAs, and mRNAs of 36 CCA tissues and 9 non-tumor bile duct tissues were obtained from The Cancer Genome Atlas (TCGA) database. The differentially expressed RNAs werre identified using the DESeq package in R. The ceRNA network was constructed in CCA based on bioinformatics generated from miRcode, miRTarBase, miRDB, and TargetScan. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using "DAVID 6.8" and R packages "Clusterprofile". Survival analysis was performed based on Kaplan-Meier curve analysis.
Results: We identified a total of 1411 differentially expressed lncRNAs, 3494 mRNAs, and 64 miRNAs between CCA and matched normal tissues. By combining the data predicted by databases with intersection RNAs, a lncRNA-miRNA-mRNA ceRNA network consisting of 116 lncRNAs, 14 miRNAs and 59 mRNAs was established. According to the survival analysis, we detected 11 DElncRNA to have a significant impact on the overall survival in patients with CCA (P < 0.05).
Conclusions: Our study identified novel lncRNAs associated with CCA progression and prognosis and provided data to further understand lncRNA-mediated ceRNA regulatory mechanisms in the pathogenesis of CCA.
Keywords: Cholangiocarcinoma; Competitive endogenous RNA; LncRNA; Survival analysis; The Cancer Genome Atlas.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.Cancer Biomark. 2018;23(4):549-559. doi: 10.3233/CBM-181684. Cancer Biomark. 2018. PMID: 30452401
-
Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).Med Sci Monit. 2019 Feb 12;25:1140-1154. doi: 10.12659/MSM.912450. Med Sci Monit. 2019. PMID: 30745559 Free PMC article.
-
Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.Cell Physiol Biochem. 2018;48(5):1953-1967. doi: 10.1159/000492519. Epub 2018 Aug 9. Cell Physiol Biochem. 2018. PMID: 30092571
-
Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.Crit Rev Eukaryot Gene Expr. 2019;29(6):539-549. doi: 10.1615/CritRevEukaryotGeneExpr.2019028740. Crit Rev Eukaryot Gene Expr. 2019. PMID: 32422009 Review.
-
Competing endogenous RNA networks and gastric cancer.World J Gastroenterol. 2015 Nov 7;21(41):11680-7. doi: 10.3748/wjg.v21.i41.11680. World J Gastroenterol. 2015. PMID: 26556995 Free PMC article. Review.
Cited by
-
The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development.J Cancer. 2019 May 26;10(11):2407-2414. doi: 10.7150/jca.32411. eCollection 2019. J Cancer. 2019. PMID: 31258745 Free PMC article. Review.
-
CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma.Aging (Albany NY). 2020 Jan 17;12(2):1047-1086. doi: 10.18632/aging.102634. Epub 2020 Jan 17. Aging (Albany NY). 2020. PMID: 31956102 Free PMC article.
-
A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma.Cancer Med. 2021 Aug;10(16):5499-5512. doi: 10.1002/cam4.4109. Epub 2021 Jun 30. Cancer Med. 2021. PMID: 34196116 Free PMC article.
-
The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.Vaccines (Basel). 2021 Apr 22;9(5):422. doi: 10.3390/vaccines9050422. Vaccines (Basel). 2021. PMID: 33922362 Free PMC article. Review.
-
miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1.Cancer Manag Res. 2020 Jul 2;12:5301-5312. doi: 10.2147/CMAR.S244167. eCollection 2020. Cancer Manag Res. 2020. Retraction in: Cancer Manag Res. 2023 Sep 14;15:1009-1010. doi: 10.2147/CMAR.S440056. PMID: 32669877 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources